Groww’s Post

It’s been a while since the IPO market was in full swing. In his recent article, James Gerlis looked at whether things might pick up again soon and what investors should keep in mind when assessing any new issuance.   Read here: https://lnkd.in/ek5zuswk   Professional investors only.

Jennifer Hughes at the Financial Times highlights that more companies could follow Reddit, Inc. onto the US stock Market. However, listing success is focused on having the right valuation agreed and being able to demonstrate growth & profitability to secure the right investors. Those were the key points that resonated in this article based on my current experience working companies who are seeking investment at this time. This was echoed in the article by Keith Canton at J.P. Morgan who said "Companies need to show growth and a path to profitability. Investors are very willing to deploy capital, but they’re still very disciplined and they’re providing us with very detailed valuation thoughts,”. Financial Times J.P. MorganThe CFO Centre UK #valuations #investors #fundraising #ipo #growth #privateequity #venturecapital

On Feb. 12, American Healthcare REIT Inc. will host a webcast after the completion of the public offering of shares of its common stock. The event is an opportunity for AHR to address questions that pre-offering stockholders may have about the offering and their respective investments. Register now. American Healthcare REIT Griffin American Healthcare REIT IV Inc Morgan Stanley Danny Prosky #alternativeinvestments #AmericanHealthcareREIT #REIT #realestateinvestmenttrust #AHR #webinar #webcast #NYSE #SecuritiesandExchangeCommission #SEC

Let's take a dive deeper into incentive stock options (ISOs), as well as the opportunities and potential complications you might face when exercising them prior to the IPO. https://lnkd.in/gddjfxw5

Beyond the Buzz: What Happens After an IPO? The confetti settles, and the headlines fade, but the journey for a company post-IPO has just begun. Let's delve into the technical aspects of what unfolds after the initial public offering. Trading Frenzy and Price Discovery: The stock price, initially set during the IPO, enters the wild west of the stock exchange. Supply and demand dictate the price as investors begin trading. Volatility is common, with the price potentially swinging significantly in the first few days. Lock-in Periods: To prevent early dumping by major shareholders and insiders, lock-in periods restrict them from selling their shares for a predetermined time (usually 3-6 months). This aims to maintain stability during the initial price discovery phase. Welcome to Reporting Season: Public companies are now subject to stricter reporting requirements. Quarterly and annual filings disclose financial performance, strategic plans, and any material developments. This transparency keeps investors informed and influences stock price movements. Life as a Public Company: The company's focus shifts towards delivering value to public shareholders. This often translates to increased pressure to meet earnings targets and maintain investor confidence. The Liquidity Loop: Public markets offer liquidity, allowing existing shareholders to sell their shares and companies to raise additional capital through secondary offerings. This can fuel further growth and expansion. The post-IPO journey is a dynamic one. Companies must navigate market forces, regulatory compliance, and investor expectations. But for those who excel, it can be a springboard to long-term success. #startupadvisory #businessadvisory #entrepreneurship #startupgrowth #businesstips #smallbusinessadvice #founders #scaleup #venturecapital #angelinvestors #businessstrategy #growthhacking #marketingtips #digitalmarketing #leadershipdevelopment #innovation #productivity #financialmanagement #successmindset #networkingtips #RaadhiAdvisors #SumithSays

The IPO market is a challenging place to find great investments. You have to sift through mountains of questionable companies and shady management teams to find the rare gem. I read several dozen initial public offering prospectuses in 2023. Some of them I got right, others I missed some key factors. Here's what I got right, what I got wrong, and how we can all better evaluate IPOs in the future. https://lnkd.in/dTCxtVvn

We predicted that 2024 public market conditions would likely continue to present significant hurdles for beauty brands looking to maximize value via an IPO for at least the first half of the year, but we may have been wrong. As stock markets rally and interest rates are set to recede, private equity firms see a window of favorability, and beauty IPO chatter is heating up. Kelly Kovack rounds up 3 beauty businesses set to IPO, including: Douglas, Galderma, and Harry's Inc. #beautybusiness #beautyindustry #finance #ipo #beautytrends

In the whirlwind world of financial markets, the allure of big names often overshadows the quiet, steady performers. The recent hype surrounding the IPOs of ARM Holdings (Nasdaq: ARM), Instacart (Nasdaq: CART), and Klaviyo (Nasdaq: KVYO) may have led many an average investor to believe that large-cap IPOs were back in vogue. However, beneath the surface of these high-profile offerings, a different story unfolds. Despite SoftBank's lofty expectations for UK-chip maker ARM, which fell well short of its targeted $60-70 billion valuation, and despite Instacart's underwhelming performance post-IPO, it's the small-cap stocks that are quietly dominating the leaderboard. These lesser-known entities are yielding returns far beyond their bigger counterparts, challenging the narrative spun by financial media and reminding us all that in the investment world, size isn't everything. While the limelight has been on big-cap IPOs, an analysis of the past 12 months reveals a different picture. Small-cap IPOs have shown remarkable performance, with 16 out of the top 20 best performing IPOs being companies with market caps below $2 billion. Even more impressively, 10 of these 16 companies boasted market caps under $1 billion. The standouts among these small-cap heroes are Genelux and Structure Therapeutics, witnessing extraordinary post-IPO gains of 324% and 293% respectively. These figures dwarf the performance of their larger counterparts, with only one large-cap stock managing to secure a spot in the top 20 IPO leaderboard over the past year. This trend underscores the potential that small-cap stocks hold, often eclipsing the returns provided by their bigger, more publicized peers. Want to be alerted to the next potential small-cap winner? RedChip is the go-to platform for small-cap stock information. With a proven track record of introducing multiple small and microcap IPOs that have witnessed triple-digit gains from their IPO pricing, RedChip offers an unparalleled edge in the investment game. Our vast resources, including CEO interviews, investor webinars, and a recently launched small-cap podcast, provide invaluable insights into the world of small-cap investing. So, if you're an investor looking to tap into the potential of small-cap stocks, this is your chance. Sign up for RedChip's free weekly newsletter today to stay updated with the latest small-cap news and upcoming IPOs. Don't miss out on the opportunity to be part of the next big success story in the small-cap universe.